|
Duration since diagnosed with blood pressure (years), Median (IQR)
|
4.5 (2–10)
|
|
Routine care, n (%)
|
|
Yes
|
45 (40.2)
|
|
Frequency of review, n (%)
|
|
Not reviewed
|
64 (57.1)
|
|
Monthly
|
32 (28.6)
|
|
Every 2 months
|
6 (5.4)
|
|
Every 3 months
|
10 (8.9)
|
|
Current treatment for hypertension, n (%)
|
|
Yes
|
53 (47.3)
|
|
Drugs participant uses for blood pressure, n (%)
|
|
Calcium channel blockers
|
43 (39.1)
|
|
Diuretics
|
14 (12.7)
|
|
Β-blockers
|
15 (13.6)
|
|
ACEIs/ARBs
|
37 (33.6)
|
|
Alpha–adrenergic agonist (methyldopa)
|
1 (1)
|
|
Drug therapy, n (%)
|
|
Mono-therapy
|
16 (28.1)
|
|
Duo-therapy
|
33 (57.9)
|
|
Multi-therapy
|
8 (14.0)
|
|
Lipid lowering therapy, n (%)
|
|
Yes
|
3 (2.6)
|
|
Herbal medication, n (%)
|
|
Yes
|
37 (33.0)
|
|
Family history of hypertension, n (%)
|
|
Yes
|
59 (52.7)
|
|
Challenges experienced on drugs, n (%)
|
|
Cost
|
47 (42.3)
|
|
Access
|
9 (8.1)
|
|
Side effects
|
4 (3.6)
|
|
Pill load
|
3 (2.7)
|
|
None
|
45 (40.5)
|
|
Previous diagnosis of diabetes mellitus, n (%)
|
|
Yes
|
24 (21.4)
|
|
Currently on medication for diabetes, n (%)
|
|
Yes
|
21 (87.5)
|
|
Level of control for sugar, n (%)
|
|
Good
|
20 (95.2)
|
|
Poor
|
1 (4.8)
|
